COV19 qcLAMP Kit
SARS-CoV-2 Infection
ApprovedCommercial (CE-IVD)
Key Facts
About BIOPIX-T
Founded in 2019 as a spin-off from IMBB-FORTH, BIOPIX-T is building a diagnostics ecosystem centered on its proprietary, 3D-printed Pebble device, which performs real-time quantitative colorimetric LAMP (qcLAMP) assays. The company has achieved CE-IVD certification for its platform and associated test kits, targeting the infectious disease diagnostics market with a focus on accessibility and ease of use. Backed by venture capital and angel investors, BIOPIX-T is led by a team of scientists and professionals aiming to expand its product portfolio and global presence.
View full company profileTherapeutic Areas
Other SARS-CoV-2 Infection Drugs
| Drug | Company | Phase |
|---|---|---|
| STANDARD Q COVID-19 Ag Test | SD BioSensor | Approved |
| STANDARD M10 SARS-CoV-2 PCR Kit | SD BioSensor | Approved |